Intelligent wearable fundus phototherapy system
Through the intelligent light source component of the intelligent wearable fundus phototherapy system, the integration of multiple treatment wavelengths and amplification of the beam through the optical components, the problem of incomplete beam coverage in the existing technology is solved, and flexible treatment of different fundus lesions is achieved, and the treatment effect is improved. .
Patent Information
- Application Number
- CN202411187636.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-28
- Publication Date
- 2024-11-15
AI Technical Summary
The existing fundus disease treatment devices have small luminous area, which makes it difficult for the treatment beam to fully illuminate the fundus area when the eyeball naturally rotates, and cannot fully meet the needs of different fundus lesions for specific wavelengths, resulting in poor treatment effect.
An intelligent wearable fundus phototherapy system is designed, including an intelligent light source component that is movably configured in a wearable device. The light emitting unit integrates four beams of different treatment wavelengths, which can switch the mixed illumination of any one or more wavelengths, and passes through the optical component. The beam expands and amplifies the beam to ensure that the beam covers all areas within the rotation range of the eye.
Through flexible switching of multiple wavelengths and beam amplification, the specific lighting needs of different fundus lesions are met, the treatment effect is improved, and the incomplete treatment area caused by eyeball rotation is avoided.
Smart Images

Figure CN118949288A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of eye medical equipment, and in particular to an intelligent wearable fundus phototherapy system. Background Art
[0002] In ophthalmic medical technology, the diagnosis and treatment of fundus diseases are constantly improving. Among them, light therapy, as a non-invasive treatment, has become an indispensable treatment for many fundus diseases. When a patient has a fundus disease, the usual method is to use a certain wavelength of light to irradiate the fundus to promote the healing of damaged or diseased cell tissues, thereby achieving the treatment of the patient's fundus disease.
[0003] However, the fundus disease treatment device in the prior art has a small light-emitting area, which makes it difficult for the treatment light beam to fully irradiate the fundus area when the eyeball rotates naturally, and cannot fully meet the needs of different fundus lesions for specific wavelengths of light, resulting in poor treatment effects.
[0004] In view of this, it is necessary to improve the fundus disease treatment device in the prior art to solve the above problems. Summary of the invention
[0005] The purpose of the present invention is to disclose an intelligent wearable fundus phototherapy system to solve the many defects existing in the fundus disease treatment devices in the prior art, especially to achieve that the therapeutic light can still fully irradiate the fundus area when the eyeball rotates naturally, and fully meet the needs of different fundus lesions for specific wavelengths of light, thereby improving the treatment effect.
[0006] To achieve the above-mentioned object, the present invention provides an intelligent wearable fundus phototherapy system, comprising: a wearable device, and an intelligent light source component movably configured on the wearable device;
[0007] The wearable device comprises: an optical component for receiving and radiating a therapeutic light beam emitted by the intelligent light source component;
[0008] The intelligent light source assembly comprises: a light emitting unit, the light emitting unit integrates light beams of four different treatment wavelengths, the light emitting unit can switch to irradiate with any one treatment wavelength, or irradiate with a mixture of any two treatment wavelengths, or irradiate with a mixture of any three treatment wavelengths, or irradiate with four treatment wavelengths simultaneously;
[0009] The light emitting surface of the light emitting unit is formed within a range of one focal length of the optical component.
[0010] As a further improvement of the present invention, the intelligent light source assembly further comprises: a light homogenizing unit which is coaxially arranged on a side of the light emitting unit facing the optical assembly to generate a therapeutic light beam.
[0011] As a further improvement of the present invention, the four therapeutic wavelengths are respectively configured as: a first therapeutic wavelength within the range of 510±20nm, a second therapeutic wavelength within the range of 590±20nm, a third therapeutic wavelength within the range of 650±20nm, and a fourth therapeutic wavelength within the range of 850±20nm.
[0012] As a further improvement of the present invention, the intelligent light source assembly further comprises: a housing, the light emitting units are symmetrically arranged in two groups along the longitudinal axis of the housing, and a control assembly;
[0013] The control component is used to adjust the light beams of different treatment wavelengths generated by the light emitting unit as well as the light beam intensity and irradiation time of the light emitting unit.
[0014] As a further improvement of the present invention, the optical assembly comprises: a first lens and a second lens respectively arranged on the same optical axis as the two groups of light-emitting units;
[0015] The control component can adjust the two groups of light-emitting units to respectively generate light beams of different treatment wavelengths and different light beam intensities and irradiation times.
[0016] As a further improvement of the present invention, the wearable device comprises: a box body, the box body is provided with an openable and closable box cover, the box cover and the box body are surrounded to form a receiving groove for receiving the intelligent light source assembly and allowing the intelligent light source assembly to move laterally;
[0017] The box body is constructed to form a lens barrel for mounting the optical component, and the optical component is arranged at an end of the lens barrel opposite to the box cover.
[0018] As a further improvement of the present invention, the light-emitting unit includes: a circuit board, and a plurality of light sources evenly arranged on the circuit board.
[0019] As a further improvement of the present invention, the intelligent light source assembly further includes: a display unit disposed on the housing, and the display unit is electrically connected to the light-emitting unit.
[0020] As a further improvement of the present invention, the intelligent light source assembly also includes: a heat conducting plate arranged on the side of the circuit board opposite to the light source for conducting heat generated by the light source, a temperature averaging plate close to the heat conducting plate for dispersing heat, and a condenser close to the temperature averaging plate for cooling the temperature averaging plate.
[0021] As a further improvement of the present invention, the intelligent wearable fundus phototherapy system further includes: a fixing structure, wherein the fixing structure includes straps connected to at least two opposite sides of the box body.
[0022] Compared with the prior art, the beneficial effects of the present invention are: by switching any one treatment wavelength for irradiation, any two treatment wavelengths for mixed irradiation, any three treatment wavelengths for mixed irradiation, or four treatment wavelengths for simultaneous irradiation through the light-emitting unit, and by integrating light beams of four different treatment wavelengths, the intelligent light source assembly can provide a variety of treatment plans, fully meeting the needs of different fundus lesions for specific wavelengths of light. By forming the light-emitting surface of the light-emitting unit within the range of one focal length of the optical assembly, the light beam will diverge and be amplified when passing through the optical assembly, thereby expanding the illumination area, so that the light beam can fully cover all fundus areas within the range of eyeball rotation, avoiding the problem of incomplete treatment area caused by eyeball rotation. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1 It is an overall schematic diagram of the intelligent wearable fundus phototherapy system disclosed in the present invention;
[0024] Figure 2 A cross-sectional view showing the connection between the wearable device and the smart light source assembly;
[0025] Figure 3 It is an overall schematic diagram of the intelligent light source component;
[0026] Figure 4 This is a three-dimensional schematic diagram of the intelligent light source assembly without the light-homogenizing sheet;
[0027] Figure 5 This is a schematic diagram of the explosion of the intelligent light source component;
[0028] Figure 6 It is a three-dimensional schematic diagram of the connection between the front shell and the circuit board. DETAILED DESCRIPTION
[0029] The present invention is described in detail below in conjunction with the various embodiments shown in the accompanying drawings, but it should be noted that these embodiments are not limitations of the present invention, and any equivalent transformations or substitutions in functions, methods, or structures made by ordinary technicians in the field based on these embodiments are all within the scope of protection of the present invention.
[0030] Please refer to Figures 1 to 6 A specific implementation of a smart wearable fundus phototherapy system is disclosed.
[0031] Ginseng Figures 1 to 4As shown, in this embodiment, the intelligent wearable fundus phototherapy system 100 includes: a wearable device 2, and an intelligent light source assembly 1 movably configured on the wearable device 2; the wearable device 2 includes: an optical assembly 20 for receiving and radiating a therapeutic light beam emitted by the intelligent light source assembly 1; the intelligent light source assembly 1 includes: a light-emitting unit 80, the light-emitting unit 80 integrates light beams of four different therapeutic wavelengths, the light-emitting unit 80 can switch to any one therapeutic wavelength for irradiation, or any two therapeutic wavelengths for mixed irradiation, or any three therapeutic wavelengths for mixed irradiation, or four therapeutic wavelengths for simultaneous irradiation; the light-emitting surface of the light-emitting unit 80 is formed within one focal length range of the optical assembly 20.
[0032] The light-emitting unit 80 can switch to any one treatment wavelength, any two treatment wavelengths mixed, any three treatment wavelengths mixed, or four treatment wavelengths simultaneously. By integrating four different treatment wavelengths of light beams, the intelligent light source assembly 1 can provide a variety of treatment options, fully meeting the needs of different fundus lesions for specific wavelengths of light. By forming the light-emitting surface of the light-emitting unit 80 within the range of one focal length of the optical assembly 20, the light beam will diverge and be amplified when passing through the optical assembly 20, thereby expanding the illumination area, so that the light beam can fully cover all fundus areas within the range of eyeball rotation, avoiding the problem of incomplete treatment area caused by eyeball rotation. The intelligent wearable fundus phototherapy system 100 solves the problem that the fundus disease treatment device in the prior art has a small light-emitting area, which makes it difficult for the treatment beam to fully irradiate the fundus area when the eyeball rotates naturally, and cannot fully meet the needs of different fundus lesions for specific wavelengths of light, resulting in poor treatment effect.
[0033] Ginseng Figure 2 and Figure 5 As shown, the intelligent light source assembly 1 further includes: a light averaging unit 50 configured with the same optical axis on the side of the light emitting unit 80 facing the optical assembly 20 to generate a therapeutic light beam. The light beam emitted by the light emitting unit 80 passes through the light averaging unit 50, passes through the optical assembly 20, and finally irradiates the human eye. The light averaging unit 50 helps to ensure that the light beam emitted by the light emitting unit 80 is more evenly distributed in the treatment area, thereby improving the treatment effect.
[0034] The four treatment wavelengths are respectively configured as: a first treatment wavelength within the range of 510±20nm, a second treatment wavelength within the range of 590±20nm, a third treatment wavelength within the range of 650±20nm, and a fourth treatment wavelength within the range of 850±20nm. It is ensured that the light emitting unit 80 can provide accurate treatment wavelengths to meet the needs of different fundus lesions for specific wavelength illumination.
[0035] Ginseng Figure 4 and Figure 5As shown, the intelligent light source assembly 1 also includes: a housing 10, two groups of light-emitting units 80 symmetrically arranged along the longitudinal axis of the housing 10, and a control assembly 30; the control assembly 30 is used to adjust the light-emitting units 80 to generate light beams of different treatment wavelengths and the light beam intensity and irradiation time of the light-emitting units 80. The light-emitting units 80 are symmetrically arranged in two groups along the longitudinal axis Q of the housing 10, which helps to ensure that the light beams can be evenly distributed and improve the treatment effect. The control assembly 30 can adjust the light-emitting units 80 to select a single wavelength, a combination of any two wavelengths, a combination of any three wavelengths, or all four wavelengths to work simultaneously according to the treatment needs. The control assembly 30 can also adjust the intensity and irradiation time of the light beam according to the requirements of the treatment plan to adapt to different treatment needs.
[0036] Ginseng Figure 2 and Figure 4 As shown, the optical component 20 includes: a first lens 201 and a second lens 202 respectively configured with the same optical axis as the two groups of light-emitting units 80; the control component 30 can adjust the two groups of light-emitting units 80 to generate light beams of different treatment wavelengths and different beam intensities and irradiation times. The control component 30 can independently control the two groups of light-emitting units 80, and each group of light-emitting units 80 generates different treatment wavelengths, beam intensities and irradiation times, so that the intelligent light source component 1 can perform differentiated treatment according to the different symptoms or severity of the left and right eyes of the patient, improve the treatment effect, and provide a more flexible treatment plan. Exemplarily, by adjusting the input current, the control component 30 can accurately control the light intensity output by the light-emitting unit 80, ranging from 0mw to 60mw. By accurately adjusting the light intensity, it can be ensured that the treatment achieves the best effect while avoiding the side effects that may be caused by excessive light intensity. By controlling the upper limit of the light intensity (60mw), the safety of the treatment is ensured and the excessive light intensity is prevented from causing harm to the patient. And it can adapt to different treatment needs, for example, a lower light intensity can be used for the treatment of sensitive parts, while a higher light intensity can be used for the treatment that requires stronger stimulation. The two groups of light-emitting units 80 are respectively the first light-emitting unit 80a and the second light-emitting unit 80b. The first light-emitting unit 80a and the second light-emitting unit 80b are respectively configured with the same optical axis as the first lens 201 and the second lens 202, which helps to distribute the light beam more evenly in the fundus area and ensure the coverage of the illuminated area even if the eyeball rotates. The intelligent light source component 1 enables the intelligent wearable fundus phototherapy system 100 to respond to the needs of different fundus diseases more flexibly. By symmetrically arranging the light-emitting units 80 and using the first lens 201, the second lens 202 and the control component 30 to adjust the wavelength and intensity of the light beam and the irradiation time, the illumination area coverage and light intensity stability during the treatment process are ensured, thereby improving the treatment effect and the patient's comfort.
[0037] Ginseng Figure 1 and Figure 2As shown, the wearable device 2 includes: a box body 21, the box body 21 is equipped with an openable and closable box cover 22, the box cover 22 and the box body 21 are arranged to form a receiving groove 23 for accommodating the intelligent light source assembly 1 and allowing the intelligent light source assembly 1 to move laterally; the box body 21 is constructed with a lens barrel 24 for installing the optical assembly 20, and the optical assembly 20 is arranged at one end of the lens barrel 24 opposite to the box cover 22.
[0038] The optical component 20 is disposed at one end of the lens barrel 24, facing the opposite direction of the box cover 22. The optical component 20 faces the user's eyes to ensure that the light beam can directly illuminate the retina area of the eyes. The box cover 22 is located outside the wearable device 2. The intelligent light source component 1 can be arranged in the accommodating groove 23 along the horizontal direction (i.e., Figure 1 The wearable device 2 can be moved in the direction indicated by the double-headed arrow X in the figure to adjust the position of the light-emitting unit 80 to adapt to different treatment needs or changes in the anatomical structure of the eye. The wearable device 2 adopts a combination design of a box body 21 and a box cover 22. A receiving groove 23 is provided in the box body 21 to allow the intelligent light source assembly 1 to move laterally. The box cover 22 can be opened and closed for easy installation and maintenance. By configuring the optical component 20 at one end of the lens barrel 24, it is ensured that the light can directly irradiate the retinal area of the eye. Even if the eyeball rotates slightly, it can ensure that the treatment light beam can fully cover the fundus area, thereby improving the effect of the treatment and ensuring the portability of the wearable device 2 and the comfort of the user. By adjusting the intelligent light source assembly 1 to move laterally, the distribution of light can be further optimized to ensure the comprehensiveness and effectiveness of the treatment.
[0039] Ginseng Figure 2 and Figure 4 As shown, the light emitting unit 80 includes: a circuit board 81, and a plurality of light sources 82 evenly arranged on the circuit board 81. Preferably, the light sources 82 are evenly arranged on the circuit board 81 in a concentric circle matrix. The number of light sources 82 may be There are 20, 30 or 40 pieces, etc. By evenly arranging the light sources 82 on the circuit board 81, it helps to reduce the volume of the overall assembly, making the structure compact and improving portability. By evenly arranging the light sources 82 in a concentric circle matrix, it can be ensured that the distribution of the light beam in the irradiation area is more uniform, and has sufficient brightness and light intensity, thereby improving the treatment effect. It should be noted that the light source 82 is preferably configured as an LED light source, and can also be configured as a laser light source, an organic light emitting diode or other light sources.
[0040] Ginseng Figure 2 and Figure 4As shown, the intelligent light source assembly 1 also includes: a display unit 60 configured in the housing 10, and the display unit 60 is electrically connected to the light-emitting unit 80. The display unit 60 includes but is not limited to a touch screen interface and a display, etc. Alternatively or in addition, the display unit 60 allows a wired or wireless connection with an external user interface (such as an external mobile phone, computer, keyboard, mouse or joystick, etc.). The display unit 60 is usually operated by a doctor or other practitioners, but in some embodiments, it can be operated by a patient. The display unit 60 can perform user login and personalized parameter setting of the light-emitting unit 80, adjust the output power by the input parameters, and adjust the emission power of the light-emitting unit 80 according to the output power. The display unit 60 can also display visual function training content. When the intelligent light source assembly 1 is rotated 180 degrees in the box body 21, the display unit 60 faces the user's eyes, and the patient can perform visual function training through the content displayed on the display unit 60. In some embodiments, the display unit 60 can also be connected to an internal camera (not shown) so that a doctor or other practitioners can observe the patient's eyes to help diagnose or guide light therapy.
[0041] Ginseng Figures 1 to 6 As shown, the housing 10 is formed by plugging the front housing 11 and the rear housing 12, the front housing 11 is constructed with a mounting groove 13 for accommodating the circuit board 81, the front housing 11 protrudes along the light beam direction of the light emitting unit 80 to form a connecting portion 14, and the light-homogenizing unit 50 is arranged at the connecting portion 14. The housing 10 is formed by plugging the front housing 11 and the rear housing 12, which helps to ensure the structural stability and easy assembly of the entire intelligent light source assembly 1. The front housing 11 is constructed with a mounting groove 13 for accommodating the circuit board 81, which helps to fix the circuit board 81 and ensure its correct position in the housing 10. The front housing 11 protrudes along the light beam direction of the light emitting unit 80 to form a connecting portion 14, which helps to position the light-homogenizing unit 50 and ensure the uniformity of the light beam.
[0042] Exemplarily, in some embodiments, by logging in as a user on the display unit 60, setting personalized parameters on the external user interface according to user information, and having the server send the personalized parameters to the smart wearable fundus phototherapy system 100 where the user logs in, the user can then receive personalized treatment.
[0043] For example, in some embodiments, when the smart light source assembly 1 is not provided with the display unit 60 , user login and personalized parameter setting can be performed after binding with the smart light source assembly 1 through an external user interface (eg, a mobile phone APP).
[0044] Exemplarily, in some embodiments, when the smart light source assembly 1 is not provided with a display unit 60, a user can log in after binding with the smart light source assembly 1 through an external user interface (for example, a mobile phone APP), and the personalized parameters can be sent to the smart wearable fundus phototherapy system 100 logged in by the user through the server.
[0045] Ginseng Figure 5 As shown, the intelligent light source assembly 1 further includes: a heat conducting plate 41 disposed on a side of the circuit board 81 opposite to the light source 82 for conducting heat generated by the light source 82, a temperature averaging plate 42 close to the heat conducting plate 41 for dispersing heat, and a condenser 43 (e.g., a copper tube) close to the temperature averaging plate 42 for cooling the temperature averaging plate 42. Through the combination of the heat conducting plate 41, the temperature averaging plate 42, and the condenser 43, efficient heat conduction and dispersion can be achieved, ensuring that the light source 82 maintains a stable operating temperature when working for a long time.
[0046] Ginseng Figure 1 As shown, the smart wearable fundus phototherapy system 100 also includes: a fixing structure 25, the fixing structure 25 includes a strap 251 connected to at least two opposite sides of the box body 21. The user wears the wearable device 2 through the fixing structure 25, and when in use, the strap 251 is wrapped around the user's head for fixing. According to the embodiments of the present disclosure, it is not limited to the above specific fixing structure 25, and any suitable head-mounted fixing structure can be used.
[0047] Ginseng Figure 5 As shown, the intelligent light source assembly 1 further includes a battery 70. The battery 70 is preferably a 3.7V rechargeable lithium battery, which provides power to the entire intelligent light source assembly 1. The use of a rechargeable lithium battery helps to improve the portability of the intelligent light source assembly 1, so that the user can use the intelligent light source assembly 1 without an external power supply. In addition, the rechargeable design reduces the frequency of replacing the battery 70, reducing operating costs and environmental impact.
[0048] The control component 30 includes: a Bluetooth module (not shown), a Wifi module (not shown), an MCU (not shown), a TYPE-C interface (not marked), a PWM infinite dimming module (not shown), a boost module (not shown), and a status indicator light (not shown). The Bluetooth module is used to realize wireless communication between the intelligent light source component 1 and an external mobile device (not shown) or other Bluetooth devices (not shown), which is convenient for remote control and monitoring. The Wi-Fi module is used to realize the connection between the intelligent light source component 1 and the Internet, and supports functions such as remote control and software update. As the control core, the MCU (microcontroller unit) is responsible for processing various signals and instructions, controlling the switch, wavelength combination and light intensity adjustment of the light-emitting unit 80, and the irradiation time. The TYPE-C interface is used for power input and data transmission. PWM infinite dimming module: used to realize smooth dimming of the light-emitting unit 80, and control the beam brightness of the light-emitting unit 80 by adjusting the duty cycle of the PWM signal. The boost module is used to increase the power supply voltage to ensure that sufficient voltage can be provided to the light source even when the battery power is low. The status indicator light is used to display the working status of the intelligent light source component 1, so that users can understand the working status of the device. With the support of Bluetooth module and Wi-Fi module, users can use external mobile devices (not shown) to remotely control the intelligent light source assembly 1 to achieve personalized treatment. Through the processing power of MCU, the intelligent light source assembly 1 can implement complex control logic and improve the accuracy of treatment. The combination of TYPE-C interface, PWM infinite dimming module and boost module helps to improve energy utilization efficiency and reduce energy consumption.
[0049] The series of detailed descriptions listed above are only specific descriptions of feasible implementation methods of the present invention. They are not intended to limit the scope of protection of the present invention. Any equivalent implementation methods or changes that do not deviate from the technical spirit of the present invention should be included in the scope of protection of the present invention.
[0050] It will be apparent to those skilled in the art that the invention is not limited to the details of the exemplary embodiments described above and that the invention can be implemented in other specific forms without departing from the spirit or essential features of the invention. Therefore, the embodiments should be considered exemplary and non-limiting in all respects, and the scope of the invention is defined by the appended claims rather than the foregoing description, and it is intended that all variations falling within the meaning and scope of the equivalent elements of the claims be included in the invention. Any reference numeral in a claim should not be considered as limiting the claim to which it relates.
[0051] In addition, it should be understood that although the present specification is described according to implementation modes, not every implementation mode contains only one independent technical solution. This description of the specification is only for the sake of clarity. Those skilled in the art should regard the specification as a whole. The technical solutions in each embodiment may also be appropriately combined to form other implementation modes that can be understood by those skilled in the art.
Claims
1. An intelligent wearable fundus phototherapy system, characterized in that: include: A wearable device, and an intelligent light source assembly movably configured on the wearable device; The wearable device comprises: an optical component for receiving and radiating a therapeutic light beam emitted by the intelligent light source component; The intelligent light source assembly comprises: a light emitting unit, the light emitting unit integrates light beams of four different treatment wavelengths, the light emitting unit can switch to irradiate with any one treatment wavelength, or irradiate with a mixture of any two treatment wavelengths, or irradiate with a mixture of any three treatment wavelengths, or irradiate with four treatment wavelengths simultaneously; The light emitting surface of the light emitting unit is formed within a range of one focal length of the optical component.
2. The smart wearable fundus phototherapy system according to claim 1, characterized in that: The intelligent light source assembly further comprises: a light averaging unit which is coaxially arranged on a side of the light emitting unit facing the optical assembly to generate a therapeutic light beam.
3. The smart wearable fundus phototherapy system according to claim 1, characterized in that: The four treatment wavelengths are respectively configured as: a first treatment wavelength within the range of 510±20 nm, a second treatment wavelength within the range of 590±20 nm, a third treatment wavelength within the range of 650±20 nm, and a fourth treatment wavelength within the range of 850±20 nm.
4. The smart wearable fundus phototherapy system according to claim 1, characterized in that: The intelligent light source assembly further comprises: a housing, the light emitting units are symmetrically arranged in two groups along the longitudinal axis of the housing, and a control assembly; The control component is used to adjust the light beams of different treatment wavelengths generated by the light emitting unit as well as the light beam intensity and irradiation time of the light emitting unit.
5. The smart wearable fundus phototherapy system according to claim 4, characterized in that: The optical assembly comprises: a first lens and a second lens respectively arranged on the same optical axis as the two groups of light-emitting units; The control component can adjust the two groups of light-emitting units to respectively generate light beams of different treatment wavelengths and different light beam intensities and irradiation times.
6. The smart wearable fundus phototherapy system according to claim 1, characterized in that: The wearable device comprises: a box body, the box body is provided with an openable and closable box cover, the box cover and the box body are surrounded to form a receiving groove for receiving the intelligent light source assembly and allowing the intelligent light source assembly to move in a lateral direction; The box body is constructed to form a lens barrel for mounting the optical component, and the optical component is arranged at an end of the lens barrel opposite to the box cover.
7. The smart wearable fundus phototherapy system according to claim 5, characterized in that: The light-emitting unit includes: a circuit board and a plurality of light sources evenly arranged on the circuit board.
8. The smart wearable fundus phototherapy system according to claim 4, characterized in that: The intelligent light source assembly further includes: a display unit disposed on the housing, and the display unit is electrically connected to the light-emitting unit.
9. The smart wearable fundus phototherapy system according to claim 7, characterized in that: The intelligent light source assembly also includes: a heat conducting plate arranged on a side of the circuit board opposite to the light source for conducting heat generated by the light source, a temperature averaging plate close to the heat conducting plate for dispersing heat, and a condenser close to the temperature averaging plate for cooling the temperature averaging plate.
10. The smart wearable fundus phototherapy system according to claim 6, characterized in that: The intelligent wearable fundus phototherapy system also includes: a fixing structure, which includes straps connected to at least two opposite sides of the box body.
